Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of The BD Veritor™ At-Home COVID-19 & Flu Test and BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B Assay

NCT05352581 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT05352581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05352581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of The BD Veritor™ At-Home COVID-19 & Flu Test and BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B Assay
Lead sponsor
Becton, Dickinson and Company
Phase
Observational
Overall status
Completed
Start date
July 21, 2022
Completion date
April 14, 2023
Enrollment
1,146 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

upper respiratory infection